Imran Babar

Chief Business Officer at Sudo BioSciences

Speaker

Imran is CBO at Sudo Biosciences and serves on the Board for Rare Genomics Institute.Previously, Imran was the CBO of Cydan, an NEA and Pfizer Ventures-backed orphan drug accelerator. He is also co-founder of several companies including Arvada. Prior to Cydan, Imran was on the venture capital team at OrbiMed Advisors and the biotechnology equity research team at Cowen. Imran is also co-founder of Rare Genomics Institute, a nonprofit dedicated to helping patients with rare diseases.Imran completed his PhD in Molecular Biology at Yale and his BA in Biology at Carleton College.